Get the Stockscreener App
1.33
0.75%
-0.01
60 Degrees Pharmaceuticals Inc stock is traded at $1.33, with a volume of 113.29K.
It is down -0.75% in the last 24 hours and down -43.88% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
See More
Previous Close:
$1.34
Open:
$1.33
24h Volume:
113.29K
Relative Volume:
0.19
Market Cap:
$1.96M
Revenue:
$502.40K
Net Income/Loss:
$-7.91M
P/E Ratio:
-0.1334
EPS:
-9.972
Net Cash Flow:
$-4.32M
1W Performance:
+1.53%
1M Performance:
-43.88%
6M Performance:
-63.38%
1Y Performance:
-83.88%
1-Day Range:
$1.2624
$1.36
1-Week Range:
$1.2624
$1.43
52-Week Range:
$1.26
$12.70
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.33 | 4.32M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
Tools to assess 60 Degrees Pharmaceuticals Inc.’s risk profileMomentum Stocks with Breakout Potential - Newser
What momentum shifts mean for 60 Degrees Pharmaceuticals Inc. Equity WarrantChart Confirmation Setup with ROI Signals - Newser
60 Degrees Pharmaceuticals Inc. stock trend forecastRisk-Managed Strategy Based on Price Analysis - Newser
Using data filters to optimize entry into 60 Degrees Pharmaceuticals Inc. Equity WarrantVolume Based Swing Signal Prediction Map - Newser
How volatile is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock compared to the marketDaily Trading Guidance To Watch Now - jammulinksnews.com
Published on: 2025-08-01 04:04:46 - Newser
What are the technical indicators suggesting about 60 Degrees Pharmaceuticals Inc.Expert Picks Tips For Smart Trading - jammulinksnews.com
What moving averages say about 60 Degrees Pharmaceuticals Inc. Equity WarrantStrategy Builder for Growth Focused Traders - Newser
60 Degrees Pharmaceuticals Inc. Equity Warrant stock trend outlook and recovery pathReversal Signal Prediction Based on Volume - Newser
Will earnings trigger a reversal in 60 Degrees Pharmaceuticals Inc. Equity WarrantPredictable Return Plan with Entry Guidance - Newser
Why is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock attracting strong analyst attentionPost Market Guidance For Smart Trading - jammulinksnews.com
What is the dividend policy of 60 Degrees Pharmaceuticals Inc. stockAI Powered Updates From AI Tools - jammulinksnews.com
How did 60 Degrees' revenue and expenses trend in Q4 2024? - AInvest
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant building a consolidation baseGrowth Summary Based on Market Positioning - Newser
What makes 60 Degrees Pharmaceuticals Inc. Equity Warrant stock price move sharplyFree Stable Entry High Return Opportunities - Newser
How 60 Degrees Pharmaceuticals Inc. stock reacts to Fed policy changesLow Risk High Confidence Watchlist Builder - Newser
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant forming a reversal patternTechnical Setup and Return Forecast Engine - Newser
What risks could impact 60 Degrees Pharmaceuticals Inc. Equity Warrant stock performance - Newser
why 60 degrees pharmaceuticals inc. stock attracts strong analyst attentionDaily Market Movers Screener with Filters - Newser
What technical models suggest about 60 Degrees Pharmaceuticals Inc.’s comebackFree Trend Following Strategy With Stop Loss - Newser
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant benefit from macro trendsChart Confirmation Setup with ROI Signals - Newser
How 60 Degrees Pharmaceuticals Inc. stock performs during market volatilityEarly Entry Planner for Swing Candidates - Newser
Real time pattern detection on 60 Degrees Pharmaceuticals Inc. stockMomentum Detection with Entry Optimization - Newser
Weiss Ratings Reaffirms Sell (E+) Rating for 60 Degrees Pharmaceuticals (NASDAQ:SXTP) - Defense World
Building trade automation scripts for 60 Degrees Pharmaceuticals Inc.Intraday Price Forecast Using Volume Models - Newser
Bullish Candlestick Pattern Forms in 60 Degrees Pharmaceuticals Inc. Equity WarrantConsistent Gain Investment Strategies Emerge - metal.it
Published on: 2025-07-29 20:10:27 - metal.it
60 Degrees Pharmaceuticals Inc. Equity Warrant Stock Recovery Path — Analyst BreakdownAI Trading Suggestions With Accuracy Focus Released - metal.it
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant rally from current levelsFree Swing Trade With Risk Management - Newser
Why 60 Degrees Pharmaceuticals Inc. Equity Warrant stock attracts strong analyst attentionEarnings Impact and Stock Reaction Analysis - Newser
How many analysts rate 60 Degrees Pharmaceuticals Inc. as a “Buy”Beginner Investor Tips With Low Risk - jammulinksnews.com
What are the latest earnings results for 60 Degrees Pharmaceuticals Inc. Equity WarrantBest Dividend Report From AI Tools - jammulinksnews.com
What is the risk reward ratio of investing in 60 Degrees Pharmaceuticals Inc. Equity Warrant stockDaily Trading Recommendation To Watch Now - jammulinksnews.com
When is 60 Degrees Pharmaceuticals Inc. stock expected to show significant growthInvest confidently with professional guidance - jammulinksnews.com
How does 60 Degrees Pharmaceuticals Inc. Equity Warrant compare to its industry peersBuild a diversified portfolio for sustainable growth - jammulinksnews.com
What catalysts could drive 60 Degrees Pharmaceuticals Inc. Equity Warrant stock higher in 2025Invest smarter with advanced market data - jammulinksnews.com
What are 60 Degrees Pharmaceuticals Inc. Equity Warrant company’s key revenue driversGet exclusive market analysis for investors - jammulinksnews.com
What institutional investors are buying 60 Degrees Pharmaceuticals Inc. Equity Warrant stockProven strategies for superior portfolio growth - jammulinksnews.com
Is it the right time to buy 60 Degrees Pharmaceuticals Inc. Equity Warrant stockAchieve consistent profits with proven strategies - jammulinksnews.com
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
60 Degrees Pharmaceuticals Inc Stock (SXTP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| XU CHERYL | Director |
Dec 13 '24 |
Buy |
1.56 |
6,000 |
9,375 |
52,078 |
| XU CHERYL | Director |
Dec 12 '24 |
Buy |
1.82 |
5,000 |
9,125 |
46,078 |
| XU CHERYL | Director |
Dec 16 '24 |
Buy |
1.45 |
2,000 |
2,900 |
54,078 |
| DOW GEOFFREY S | President and CEO |
Dec 09 '24 |
Buy |
1.27 |
35,823 |
45,563 |
94,580 |
| DOW GEOFFREY S | President and CEO |
Dec 06 '24 |
Buy |
1.20 |
20,579 |
24,672 |
58,757 |
| DOW GEOFFREY S | President and CEO |
Dec 05 '24 |
Buy |
1.11 |
17,549 |
19,520 |
38,178 |
| DOW GEOFFREY S | President and CEO |
Nov 21 '24 |
Buy |
0.91 |
3,500 |
3,195 |
20,629 |
| DOW GEOFFREY S | President and CEO |
Nov 19 '24 |
Buy |
0.90 |
2,500 |
2,248 |
16,129 |
| DOW GEOFFREY S | President and CEO |
Nov 20 '24 |
Buy |
0.92 |
1,000 |
924 |
17,129 |
| XU CHERYL | Director |
Aug 27 '24 |
Buy |
1.70 |
5,000 |
8,500 |
41,078 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):